We are here to break the isolation so often felt by those with these rare diseases, and we would be delighted to welcome you into our 'family'.
The aim of our website is to direct you as quickly as possible to our support services and to information you can trust on multiple endocrine neoplasia (MEN) types 1, 2, and 3, medullary thyroid cancer (MTC), familial medullary thyroid cancer (FMTC), adrenal gland tumours (phaeochromocytomas), parathyroid hyperplasia, paragangliomas, familial isolated pituitary adenoma (FIPA) and succinate dehydrogenase (SDH) disorders.
Please join us for our free patient information event on Saturday 6th May in Central Manchester!
All those affected by multiple endocrine neoplasia (MEN), succinate dehydrogenase syndromes (SDHx) and adrenocortical cancer (ACC) are invited to this popular day-long event to listen to some fascinating talks and participate in some useful workshops. Sessions include those on Transition, Understanding Research Articles, Using Social Media for Support, as well as patient experiences and an overview of genetic counselling.
Refreshments, lunch and a creche are all available for free.
We are delighted to announce that Professor Maralyn Druce has joined AMEND's Medical Advisory Team.
Professor Druce, a consultant endocrinologist from St Bartholomew's Hospital in London has special expertise in medical education and we know that she will be a great addition to our wonderful team.